|
UBE2V1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.683200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.196600E-01 |
| Normal-vs-Stage2 |
6.315400E-01 |
| Normal-vs-Stage3 |
1.884020E-01 |
| Normal-vs-Stage4 |
3.417600E-01 |
| Stage1-vs-Stage2 |
7.605600E-01 |
| Stage1-vs-Stage3 |
1.720820E-01 |
| Stage1-vs-Stage4 |
3.374400E-01 |
| Stage2-vs-Stage3 |
5.099400E-01 |
| Stage2-vs-Stage4 |
5.537600E-01 |
| Stage3-vs-Stage4 |
9.828200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.199600E-01 |
| Normal-vs-AfricanAmerican |
4.404200E-01 |
| Normal-vs-Asian |
2.438800E-01 |
| Caucasian-vs-AfricanAmerican |
8.698600E-01 |
| Caucasian-vs-Asian |
1.092810E-01 |
| AfricanAmerican-vs-Asian |
1.103820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.986600E-01 |
| Normal-vs-Female |
1.740370E-02 |
| Male-vs-Female |
1.289630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.525800E-01 |
| Normal-vs-Extreme_Weight |
3.941400E-01 |
| Normal-vs-Obese |
4.082500E-02 |
| Normal-vs-Extreme_Obese |
1.745830E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.262000E-01 |
| Normal_Weight-vs-Obese |
1.508760E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.008200E-02 |
| Extreme_Weight-vs-Obese |
9.580800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.742200E-02 |
| Obese-vs-Extreme_Obese |
9.219400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.987800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.393800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.519000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.594500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.673800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.458100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.536900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.159100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.824500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.018430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.314400E-01 |
| Normal-VS-Type2 PRCC |
2.804000E-02 |
| Normal-VS-KIRP CIMP |
7.776100E-03 |
| Normal-VS-Unclassified PRCC |
9.174400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.063700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.216700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.979620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.17860000004022E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
7.580500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.331700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.180000E-01 |
| Normal-vs-N1 |
1.639520E-02 |
| Normal-vs-N2 |
9.898800E-01 |
| N0-vs-N1 |
1.557540E-03 |
| N0-vs-N2 |
7.097200E-01 |
| N1-vs-N2 |
3.063000E-01 |
|
|
